Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

GUIDANCE: Merck Financial Services GmbH € bmk 2yr FRN & 4.5yr & 7yr & 10yr Sr Unsec; 3mE+45a & MS+60a & MS+80a & MS+100a

IGC European Market: Deal Flow - General

Issuer

Term

Maturity

Size

Ranking

Type

ISIN

IPT

Guidance

Merck Financial Services GmbH

2yr

19-Nov-28

bmk

Sr Unsec

Floating

XS3560944848

3mE+70a

3mE+45a

Merck Financial Services GmbH

4.5yr

19-May-31

bmk

Sr Unsec

Fixed

XS3560945571

MS+85a

MS+60a

Merck Financial Services GmbH

7yr

19-Nov-33

bmk

Sr Unsec

Fixed

XS3560945142

MS+110a

MS+80a

Merck Financial Services GmbH

10yr

19-Nov-36

bmk

Sr Unsec

Fixed

XS3560945902

MS+130a

MS+100a


Guidance:
2yr: 3mE+45a (+/-2bps) - Books 1.8bn+
4.5yr: MS+60a - Books 3bn+
7yr: MS+80a - Books 3.8bn+
10yr: MS+100a - Books 4.5bn+

IPTs: 2yr: 3mE+70a 4.5yr: MS+85a 7yr: MS+110a 10yr: MS+130a


  • Issuer: Merck Financial Services GmbH
  • Guarantor: Merck KGaA (Ticker: MRKGR, Country: DE)
  • Expected Issue Ratings: A3 by Moody’s / A by S&P
  • Issuer LEI: 549300OELEN3ZS5RB682
  • Guarantor LEI: 529900OAREIS0MOPTW25
  • Format: Senior, Unsecured, Bearer, initially represented by a Temporary Global Note exchangeable for a Permanent Global Note
  • Total Max Deal Size: €3.7bn
  • Size: €-Benchmark (each tranche)
  • Settlement: 19-Nov-26 (T+3)
  • Maturity:
    • 2yr: 19-Nov-28
    • 4.5yr: 19-May-31
    • 7yr: 19-Nov-33
    • 10yr: 19-Nov-36
  • Coupon:
    • 2yr: Floating, Act/360, Quarterly, Modified Following, Adjusted
    • 4.5yr: Fixed, Actual/Actual (ICMA), Annual, Following, Unadjusted, Short first
    • 7yr: Fixed, Actual/Actual (ICMA), Annual, Following, Unadjusted
    • 10yr: Fixed, Actual/Actual (ICMA), Annual, Following, Unadjusted
  • Par call:
    • 2yr: -
    • 4.5yr: 1-month
    • 7yr: 3-month
    • 10yr: 3-month
  • Tax call: Yes (all tranches)
  • Clean-up call:
    • 2yr: -
    • 4.5yr: Yes (75%)
    • 7yr: Yes (75%)
    • 10yr: Yes (75%)
  • CoC: Yes (at par) (all tranches)
  • Make-Whole Call:
    • 2yr: -
    • 4.5yr: Yes
    • 7yr: Yes
    • 10yr: Yes
  • Docs: DIP / Lux. Listing (regulated market) / German Law / €100k + €100k
  • Selling Restrictions: As per Base Prospectus dated 13 March 2026 (“Base Prospectus”) and supplemented on 13 November 2026 (“Supplement”), (see section “Subscription and Sale – Selling Restrictions”), TEFRA D
  • Use of proceeds: General corporate purposes, including financing of recently announced acquisitions
  • Target Market: Manufacturer target market (MIFID II / UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels).
  • Prohibition of sales to EEA and UK retail investors: No EEA PRIIPs key information document (KID) or UK CCI disclosure document required by the UK FCA Product Disclosure Sourcebook (DISC) has been prepared as not available to retail in EEA, the UK or elsewhere.
  • Global Coordinators: BNP Paribas, Deutsche Bank (B&D), J.P. Morgan
  • Active Bookrunners: BBVA, BNP Paribas, Deutsche Bank, J.P. Morgan, SEB, UniCredit
  • Passive Bookrunners: Bank of China, Barclays, BofA Securities, Commerzbank, DZ Bank, Mizuho, NatWest, Société Générale
  • Advertisement: This communication is not an advertisement for the purposes of Regulation (EU) 2017/1129 and underlying legislation. It is not a prospectus. The Base Prospectus and Supplement are available at https://www.luxse.com.The final terms, when published, will be available at https://www.luxse.com
  • Timing: Books open, today's business
  • Books Subject: 12.30 UKT
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.